Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RDHL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2023 35.04M
March 31, 2023 58.83M
December 31, 2022 158.87M
September 30, 2022 157.19M
June 30, 2022 167.97M
March 31, 2022 167.05M
December 31, 2021 181.19M
September 30, 2021 186.34M
June 30, 2021 203.67M
March 31, 2021 220.13M
December 31, 2020 180.24M
September 30, 2020 168.98M
June 30, 2020 166.37M
March 31, 2020 143.48M
December 31, 2019 74.10M
September 30, 2019 40.24M
June 30, 2019 49.69M
March 31, 2019 58.13M
December 31, 2018 62.41M
September 30, 2018 53.38M
June 30, 2018 37.85M
March 31, 2018 46.39M
December 31, 2017 57.34M
September 30, 2017 50.24M
June 30, 2017 61.93M
Date Value
March 31, 2017 69.43M
December 31, 2016 74.14M
September 30, 2016 48.89M
June 30, 2016 56.26M
March 31, 2016 61.55M
December 31, 2015 66.83M
September 30, 2015 71.74M
June 30, 2015 34.38M
March 31, 2015 41.23M
December 31, 2014 29.08M
September 30, 2014 33.27M
June 30, 2014 39.25M
March 31, 2014 40.58M
December 31, 2013 14.34M
September 30, 2013 16.22M
June 30, 2013 17.02M
March 31, 2013 18.69M
December 31, 2012 20.10M
September 30, 2012 15.31M
June 30, 2012 16.58M
March 31, 2012 18.45M
December 31, 2011 20.19M
September 30, 2011 21.72M
June 30, 2011 23.25M
March 31, 2011 23.69M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Teva Pharmaceutical Industries Ltd. 39.86B
MediWound Ltd. 71.88M
Purple Biotech Ltd. 14.17M
Sol-Gel Technologies Ltd. 53.76M
PolyPid Ltd. 15.23M